Brian Anderton

Glycogen synthase kinase‐3 inhibition is integral to long‐term potentiation

Claudie Hooper, V. А. Markevich, Florian Plattner et al. · European Journal of Neuroscience · 2007 · 339 citations

Life Sciences, Neurobiology, Neuroscience +16

Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule‐binding repeat domains as demonstrated by new specific monoclonal antibodies

R. De Silva, Tammaryn Lashley, Graham Gibb et al. · Neuropathology and Applied Neurobiology · 2003 · 213 citations

Life Sciences, Neurology, Neuroscience +17

The active form of glycogen synthase kinase-3? is associated with granulovacuolar degeneration in neurons in Alzheimer's disease

Allal Boutajangout, Karelle Leroy, M. Authelet et al. · Acta Neuropathologica · 2002 · 181 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Abnormalities of Wnt signalling in schizophrenia – evidence for neurodevelopmental abnormality

David Cotter, Robert Kerwin, Safa Al-Sarraji et al. · Neuroreport · 1998 · 154 citations

Medicine, Neurobiology, Neuroscience +17

Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease

Abdul Hye, Fiona Kerr, Nicola Archer et al. · Neuroscience Letters · 2004 · 122 citations

Life Sciences, Neurobiology, Neuroscience +14